{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:07:55Z","timestamp":1792292875731,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.annder.2018.07.009","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:42:10Z","timestamp":1540323730000},"page":"676-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Ulc\u00e9rations buccales aphto\u00efdes inaugurales d\u2019une maladie inflammatoire chronique de l\u2019intestin induite par le s\u00e9cukinumab"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2752-5766","authenticated-orcid":false,"given":"X.","family":"Grimaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-6365","authenticated-orcid":false,"given":"S.","family":"Leducq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Goupille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Miquelestorena-Standley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.07.009_bib0110","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jaci.2017.02.013","article-title":"Biologic response modifiers: indications, implications, and insights","volume":"139","author":"Davis","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.annder.2018.07.009_bib0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152812800392805","article-title":"The IL23\/Th17\u00a0pathway as a therapeutic target in chronic inflammatory diseases","volume":"11","author":"Toussirot","year":"2012","journal-title":"Inflamm Allergy Drug Targets"},{"key":"10.1016\/j.annder.2018.07.009_bib0120","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1053\/j.gastro.2012.07.084","article-title":"Mo2083, a randomized, double-blind, placebo-controlled study to evaluate the safety. Tolerability, and efficacy of AMG 827\u00a0in subjects with moderate to severe Crohn's disease","volume":"143","author":"Targan","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annder.2018.07.009_bib0125","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"S\u00e9cukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.annder.2018.07.009_bib0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/gutjnl-2012-304154","article-title":"S\u00e9cukinumab failure in Crohn's disease: the yeast connection?","volume":"62","author":"Colombel","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.annder.2018.07.009_bib0135","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/ajg.2016.298","article-title":"A randomized, double-blind. Placebo-controlled phase 2\u00a0study of brodalumab in patients with moderate-to-severe Crohn's disease","volume":"111","author":"Targan","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.annder.2018.07.009_bib0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.annder.2012.11.006","article-title":"Ulc\u00e9rations buccales aphto\u00efdes persistantes associ\u00e9es au tocilizumab\u00a0: deux cas","volume":"140","author":"Samimi","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2018.07.009_bib0145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jdcr.2016.07.009","article-title":"Severe, ulcerative, lichenoid mucositis associated with s\u00e9cukinumab","volume":"2","author":"Thompson","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2018.07.009_bib0150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1601-0825.2011.01840.x","article-title":"Urban legends: recurrent aphthous stomatitis","volume":"17","author":"Baccaglini","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.annder.2018.07.009_bib0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/apt.13217","article-title":"Review article: non-malignant oral manifestations in inflammatory bowel diseases","volume":"42","author":"Katsanos","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annder.2018.07.009_bib0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/annrheumdis-2016-eular.3684","article-title":"OP0113\u00a0No increased incidence of inflammatory bowel disease among S\u00e9cukinumab-treated patients with moderate to severe Psoriasis, psoriatic arthritis, or ankylosing spondylitis: data from 14\u00a0phase 2\u00a0and phase 3\u00a0clinical studies","volume":"75","author":"Schreiber","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2018.07.009_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/872632","article-title":"The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption","volume":"2013","author":"Rashid","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.annder.2018.07.009_bib0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17\u00a0immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.annder.2018.07.009_bib0175","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","article-title":"Interactions between commensal fungi and the C-Type Lectin Receptor Dectin-1\u00a0influence colitis","volume":"336","author":"Iliev","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.annder.2018.07.009_bib0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1055\/s-0030-1255931","article-title":"Multiple ulcers in the small and large intestines occurred during tocilizumab therapy for rheumatoid arthritis","volume":"43","author":"Iwasa","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.annder.2018.07.009_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s10620-007-9849-6","article-title":"Serum Interleukin-6. Soluble interleukin-6\u00a0receptor and Crohn's disease activity","volume":"53","author":"Nancey","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.annder.2018.07.009_bib0190","doi-asserted-by":"crossref","first-page":"e54562","DOI":"10.1371\/journal.pone.0054562","article-title":"Distinct profiles of effector cytokines mark the different phases of Crohn's disease","volume":"8","author":"Zorzi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.annder.2018.07.009_bib0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/biof.9","article-title":"Evidence for the role of Th17\u00a0cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6\u00a0receptor antibody","volume":"35","author":"Mihara","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.annder.2018.07.009_bib0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","article-title":"Interleukins 1beta and 6\u00a0but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.annder.2018.07.009_bib0205","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/art.24126","article-title":"Interleukin-6\u00a0blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17\u00a0responses","volume":"58","author":"Fujimoto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2018.07.009_bib0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/imm.12334","article-title":"Endogenous interleukin-6\u00a0amplifies interleukin-17\u00a0production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis","volume":"143","author":"Ferreira","year":"2014","journal-title":"Immunology"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381830499X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S015196381830499X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:17Z","timestamp":1758971177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S015196381830499X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S015196381830499X"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.009","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ulc\u00e9rations buccales aphto\u00efdes inaugurales d\u2019une maladie inflammatoire chronique de l\u2019intestin induite par le s\u00e9cukinumab","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}